Product Images Budesonide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Budesonide NDC 0093-6816 by Teva Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image 1
Budesonide Inhalation Suspension 0.5 mg/2 mL, 30s (6 pouches of five 2 mL vials each) Carton, Part 1 of 2 - image 10
This is a description of a medication called Budesonide Inhalation Suspension with an NDC code. The package contains six pouches of five vials each for a total of 30 unit-dose vials. The medication is used for oral inhalation only and the vials should be used within 2 weeks of opening the foil envelope. The medication should be stored at 20° to 25°C (68° to 77°F) and should not be frozen. The non-varnished area of the package contains serialization coding area, and the package should be protected from light. The medication is manufactured in England by Norton Healthcare Limited T/A IVAX Pharmaceuticals UK and is distributed by Teva Pharmaceuticals USA, Inc. The description includes instructions on how to use the medication.*
image 2
image 3
The text appears to be incomplete and does not provide sufficient context to generate a useful description.*
image 4
image 5
image 6
image 7
image 8
image 9
This is a description of Budesonide Inhalation Suspension, a medication for oral inhalation use only. It comes in 6 pouches of five 2 mL vials (30 unit-dose vials) containing 0.25 mg of micronized budesonide, USP. The medication is manufactured in England by Norton Healthcare Limited T/A IVAX Pharmaceuticals UK and is distributed in North Wales, PA by Teva Pharmaceuticals USA, Inc. The medication should be used within 2 weeks of opening the foil envelope and is intended for use only in a jet nebulizer, not an ultrasonic nebulizer. The patient should follow the Patient Instructions carefully and use it as directed by a doctor. The medication should be stored at 20° to 25°C (68° to 77°F) in a foil envelope placed upright in the carton and protected from light, and should not be frozen. Inactive Ingredients include citric acid monohydrate, disodium edetate, polysorbate 80, sodium chloride, tri-sodium citrate dihydrate, and water for injection.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.